check_circleStudy Completed
Atrial fibrillation
Bayer Identifier:
17671
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Observational study to assess sociodemographic and clinical features of patients treated with rivaroxaban in routine clinical practice of hematologists, cardiologists and internists of Spain
Trial purpose
Depict demographic and clinical features of patients with atrial fibrillation treated with rivaroxaban to prevent stroke and pulmonary embolism in routine clinical practice
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
2251Trial Dates
October 2014 - May 2015Phase
N/ACould I Receive a placebo
NoProducts
Xarelto (Rivaroxaban, BAY59-7939)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Spain |
Primary Outcome
- Demographic Datadate_rangeTime Frame:At recruitment visitenhanced_encryptionNoSafety Issue:
- Medical Historydate_rangeTime Frame:At recruitment visitenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Assess regional differences among the different Spanish autonomous communities on the management of patients with rivaroxaban treatment during the routine clinical practiceBy use of Informe de Posicionamiento Terapéutico (Spanish Questionnaire)date_rangeTime Frame:At recruitment visitenhanced_encryptionNoSafety Issue:
- Adherence to rivaroxaban treatmentBy use of Morisky-Green questionnairedate_rangeTime Frame:At recruitment visitenhanced_encryptionNoSafety Issue:
- Assess the satisfaction of rivaroxaban treatmentBy use of Anti-Clot Treatment Scale (ACTS) questionnairedate_rangeTime Frame:At recruitment visitenhanced_encryptionNoSafety Issue:
- Assess the quality of life in patientsBy use of Short-Form 12 Health Survey,version 2 (SF12v2) questionnairedate_rangeTime Frame:At recruitment visitenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A